Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma

Although cutaneous squamous cell carcinoma (cSCC) is treatable in the majority of cases, deadly invasive and metastatic cases do occur. To date there are neither reliable predictive biomarkers of disease progression nor FDA-approved targeted therapies as standard of care. To address these issues, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Ashley N., McClanahan, Danielle, Jacobs, James, Jeng, Sophia, Vigoda, Myles, Blucher, Aurora S., Zheng, Christina, Yoo, Yeon Jung, Hale, Carolyn, Ouyang, Xiaoming, Clayburgh, Daniel, Andersen, Peter, Tyner, Jeffrey W., Bar, Anna, Lucero, Olivia M., Leitenberger, Justin J., McWeeney, Shannon K., Kulesz-Martin, Molly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2020
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476409/
https://www.ncbi.nlm.nih.gov/pubmed/32843430
http://dx.doi.org/10.1101/mcs.a005439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476409/
https://www.ncbi.nlm.nih.gov/pubmed/32843430
http://dx.doi.org/10.1101/mcs.a005439

Ejemplares similares